Euro-Med Laboratories Phils Inc
Euro-Med Laboratories Phils Inc operates in Pharmaceuticals.
Euro-Med Laboratories Phils Inc (EURO) - Total Assets
Latest total assets as of December 2022: ₱10.06 Billion PHP
Based on the latest financial reports, Euro-Med Laboratories Phils Inc (EURO) holds total assets worth ₱10.06 Billion PHP as of December 2022.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Euro-Med Laboratories Phils Inc - Total Assets Trend (2014–2022)
This chart illustrates how Euro-Med Laboratories Phils Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Euro-Med Laboratories Phils Inc - Asset Composition Analysis
Current Asset Composition (December 2022)
Euro-Med Laboratories Phils Inc's total assets of ₱10.06 Billion consist of 44.0% current assets and 56.0% non-current assets.
| Asset Category | Amount (PHP) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₱0.00 | 6.1% |
| Accounts Receivable | ₱1.44 Billion | 14.3% |
| Inventory | ₱1.54 Billion | 15.3% |
| Property, Plant & Equipment | ₱4.96 Billion | 49.3% |
| Intangible Assets | ₱268.13 Million | 2.7% |
| Goodwill | ₱0.00 | 0.0% |
Asset Composition Trend (2014–2022)
This chart illustrates how Euro-Med Laboratories Phils Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Euro-Med Laboratories Phils Inc's current assets represent 44.0% of total assets in 2022, a decrease from 53.7% in 2014.
- Cash Position: Cash and equivalents constituted 6.1% of total assets in 2022, up from 0.0% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, unchanged from 2.0% in 2014.
- Asset Diversification: The largest asset category is property, plant & equipment at 49.3% of total assets.
Euro-Med Laboratories Phils Inc Competitors by Total Assets
Key competitors of Euro-Med Laboratories Phils Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
|
Korea | ₩529.96 Billion |
|
DongKoo Bio&Pharma Co. Ltd
KQ:006620
|
Korea | ₩269.00 Billion |
|
NatureCell Co.Ltd
KQ:007390
|
Korea | ₩71.32 Billion |
|
Sam-A Pharm. Co. Ltd
KQ:009300
|
Korea | ₩246.13 Billion |
|
Kyung Dong Pharmaceutical Co. Ltd
KQ:011040
|
Korea | ₩291.47 Billion |
|
WooGene B&G Co. Ltd
KQ:018620
|
Korea | ₩117.10 Billion |
|
Oscotec Inc
KQ:039200
|
Korea | ₩154.14 Billion |
|
EstechPharma Co. Ltd
KQ:041910
|
Korea | ₩192.01 Billion |
Euro-Med Laboratories Phils Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Euro-Med Laboratories Phils Inc generates 0.42x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Euro-Med Laboratories Phils Inc generates $ 1.99 in net profit.
Euro-Med Laboratories Phils Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.33 | 1.33 | 1.87 |
| Quick Ratio | 0.87 | 0.90 | 1.49 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₱1.10 Billion | ₱ 973.51 Million | ₱ 2.09 Billion |
Euro-Med Laboratories Phils Inc - Advanced Valuation Insights
This section examines the relationship between Euro-Med Laboratories Phils Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 3.8% |
| Total Assets | ₱10.06 Billion |
| Market Capitalization | $163.85 USD |
Valuation Analysis
Below Book Valuation: The market values Euro-Med Laboratories Phils Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Euro-Med Laboratories Phils Inc's assets grew by 3.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Euro-Med Laboratories Phils Inc (2014–2022)
The table below shows the annual total assets of Euro-Med Laboratories Phils Inc from 2014 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | ₱10.06 Billion | +3.79% |
| 2021-12-31 | ₱9.69 Billion | -3.78% |
| 2020-12-31 | ₱10.07 Billion | -2.58% |
| 2019-12-31 | ₱10.34 Billion | +6.89% |
| 2018-12-31 | ₱9.67 Billion | +7.38% |
| 2017-12-31 | ₱9.01 Billion | -2.97% |
| 2016-12-31 | ₱9.28 Billion | +1.73% |
| 2015-12-31 | ₱9.13 Billion | -4.79% |
| 2014-12-31 | ₱9.58 Billion | -- |